Navigation Links
Dietary supplements for patients after lung injury do not appear to improve outcomes; may be harmful

CHICAGO In contrast to findings of previous studies, patients who experienced an acute lung injury, such as from pneumonia or sepsis, and received dietary supplements including omega-3 fatty acids and antioxidants had more days on a ventilator, more days in the intensive care unit (ICU), and a non-statistically significant increase in the rate of death, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the European Society of Intensive Care Medicine meeting in Berlin.

"Patients at risk of developing acute lung injury (ALI) have omega-3 (n-3) levels approximately 25 percent of normal and those with established ALI have n-3 levels as low as 6 percent of normal, suggesting a potential role for n-3 dietary supplementation in patients with ALI," according to background information in the article. Preclinical data indicate that the n-6 γ-linolenic acid (GLA; a fatty acid), in conjunction with the n-3 fatty acid eicosapentaenoic acid (EPA), may also be beneficial in ALI. Three randomized controlled studies, conducted in patients with ALI or sepsis-induced respiratory failure, demonstrated an association between the administration of an enteral (oral) formula enriched in n-3 fatty acids, GLA, and antioxidants and improved outcomes on some measures. These supplements may modulate systemic inflammatory response and improve oxygenation and outcomes in patients with ALI. However, interpretation of these results is limited by the small sample sizes and as-treated analyses of only those patients who tolerated full enteral nutrition.

Todd W. Rice, M.D., M.Sc., of the Vanderbilt University School of Medicine, Nashville, Tenn., and colleagues conducted a study to examine the effects of supplementation of n-3 fatty acids, GLA, and antioxidants on clinical outcomes in patients with ALI in a phase 3 trial. The researchers hypothesized that a twice-daily bolus (a large dosage) administration of these supplements would increase the ratio of n-3 to n-6 fatty acids, reduce inflammatory mediators, and improve certain clinical outcomes. The OMEGA study was a randomized, placebo-controlled, multicenter trial conducted from January 2008 through February 2009. Participants were 272 adults within 48 hours of developing ALI requiring mechanical ventilation whose physicians intended to start enteral nutrition at 44 hospitals in the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. The intervention consisted of twice-daily enteral supplementation of n-3 fatty acids (docosahexaenoic acid [DHA] and EPA), GLA, and antioxidants compared with an isocaloric control. The primary measured outcome was the number of ventilator-free days to study day 28.

The study was stopped early for futility at the first interim analysis after 143 patients had been randomized to receive the n-3 supplement and 129 to receive the isocaloric control. All patients had complete follow-up to the earlier of hospital discharge or day 60.

The n-3 study supplement increased plasma EPA levels 8-fold on days 3, 6, and 12, whereas levels in control patients remained unchanged. The researchers found that the n-3 supplement group had fewer ventilator-free days to study day 28 compared with controls (14.0 vs. 17.2) and fewer ICU-free days (14.0 vs. 16.7). "In the n-3 group, 38 of the 143 patients (26.6 percent) died prior to day 60 or hospital discharge compared with 21 of the 129 (16.3 percent) in the control group. When adjusted for baseline variables previously shown to be associated with mortality in ALI, the n-3 group had 25.1 percent 60-day mortality vs. 17.6 percent in the control group [not statistically significant]."

In addition, the n-3 supplement did not protect from hospital-acquired infections or improve nonpulmonary organ function. Patients receiving the n-3 supplement had more frequent instances of gastrointestinal intolerance.

"This study suggests that twice-daily enteral supplementation of n-3 fatty acids, GLA, and antioxidants change plasma levels of n-3 fatty acids but do not improve clinical outcomes or biomarkers of systemic inflammation in patients with ALI and in fact may be harmful," the authors conclude.

(JAMA. 2011;306[14]:1574-1581. Available pre-embargo to the media at

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Please Note: The presentation of this study will be available online at beginning at 8:45 a.m. CT Wednesday, October 5.

Editorial: Pharmaconutrition in Acute Lung Injury

Deborah J. Cook, M.D., M.Sc., of McMaster University Health Sciences Center, Hamilton, Ontario, and Daren K. Heyland, M.D., M.Sc., of Queens University, Kingston, Ontario, Canada write in an accompanying editorial that more research is needed regarding the use of pharmaconutrition.

"Translational research as was used in the OMEGA trial will elucidate effects, or lack thereof, on inflammatory, immunologic, metabolic, and other processes. Clinical research will test whether modulating pathophysiology improves morbidity and mortality. Larger trials will help to inform practitioners regarding which interventions do more good than harm, which do more harm than good, and which truly have no effect. Interdisciplinary collaboration incorporating basic principles of nutrition will be needed to accelerate the generation of new knowledge. Currently, international audits of nutrition practice suggest that use of these and other pharmaconutrients is low. If and when the time is ripe, the fruits of these labors will be harvested in knowledge translation activities that drive quality improvement to help improve the care of critically ill patients around the world."

(doi:10.1001/jama.2011.1470. Available pre-embargo to the media at

Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.


Contact: Craig Boerner
JAMA and Archives Journals

Related medicine news :

1. Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women
2. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
3. The effect of dietary supplements, acids and animal protein on gastrointestinal disorders
4. Purity 12 Science: How this Dietary Supplement, Healthy Beverage and Skin Care Company is Gaining Momentum in a Down Economy
5. Gestational Diabetes Linked to Serotonin and Dietary Protein
6. Study shows how dietary supplement may block cancer cells
7. Dietary Cocoa Flavanols Improve Vascular And Blood Pressure Measures For Coronary Artery Disease Patients
8. Concentration, timing and interactions are key when it comes to dietary compounds
9. How safe and effective are herbal dietary supplements?
10. Diabetes or not, dietary habits of Aftrican-Americans are similar
11. Study findings show value of dietary supplement SAMe in treatment of adults with major depressive disorders
Post Your Comments:
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology: